🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Tushar Tomar

PamGene (Netherlands)

ORCID: 0000-0002-3344-7605

Also affiliated with Lava Therapeutics (Netherlands)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors”.

Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors

Cancer Research(2020)10.1158/0008-5472.can-20-1365

N/A

0DataRank · unranked

65 citations

Kai Pollard, Amy N. Allen, Tushar Tomar, Dirk Pijnenburg, Zhan Yao +3 more

Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia

International Journal of Molecular Sciences(2020)10.3390/ijms21228823

N/A

0DataRank · unranked

22 citations

Khaled Alganem, Ali Sajid Imami, Nicholas Henkel, F. Charles Brunicardi, Shi‐He Liu +5 more

Kinome Array Profiling of Patient-Derived Pancreatic Ductal Adenocarcinoma Identifies Differentially Active Protein Tyrosine Kinases

International Journal of Molecular Sciences(2020)10.3390/ijms21228679

N/A

0DataRank · unranked

40 citations

Khaled Alganem, Ali Sajid Imami, F. Charles Brunicardi, Shi‐He Liu, Rammohan Shukla +4 more